Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies

Kerry A. Rogers, Luay Mousa, Qiuhong Zhao, Seema A. Bhat, John C. Byrd, Zeinab El Boghdadly, Tomas Guerrero, Lauren B. Levine, Fabienne Lucas, Polina Shindiapina, Audrey M. Sigmund, Matthew Sullivan, Tracy E. Wiczer, Jennifer A. Woyach, Farrukh T. Awan